Wealthcare Advisory Partners’s Regenxbio RGNX Stock Holding History

Wealthcare Advisory Partners’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$72K	–	1291
2018 Q2	$72K	Buy	+1,000	New	+$47.8K	0.01%	394

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wealthcare Advisory Partners's RGNX Position: Q3 2018 in Review

Wealthcare Advisory Partners sold out of Regenxbio (RGNX) in Q3 2018, closing a stake of 1,000 shares — an estimated $72K sold.

Wealthcare Advisory Partners first reported a position in RGNX in Q2 2018 and held it in 1 quarter. The position peaked at $72K in Q2 2018. 203 funds tracked by Wall St. Rank hold RGNX as of Q3 2018.

Wealthcare Advisory Partners reported no remaining Regenxbio position as of Q3 2018 after selling out during the quarter.
Wealthcare Advisory Partners sold 1,000 Regenxbio shares in Q3 2018, an estimated $72K.
Wealthcare Advisory Partners first reported a position in Regenxbio in Q2 2018 and held it in 1 quarter.
Wealthcare Advisory Partners's Regenxbio position peaked at $72K in Q2 2018.
203 funds tracked by Wall St. Rank held Regenxbio as of Q3 2018.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2018, filed 14 Nov 2018.